Adipose-derived stromal cells cultured in a low-serum medium, but not bone marrow-derived stromal cells, impede xenoantibody production

Xenotransplantation

Volumn 18, Issue 3, 2011, Pages 196-208

  Saka, Yosuke ^a   Furuhashi, Kazuhiro ^a   Katsuno, Takayuki ^a   Kim, Hangsoo ^a   Ozaki, Takenori ^a   Iwasaki, Kenta ^b   Haneda, Masataka ^b   Sato, Waichi ^a   Tsuboi, Naotake ^a   Ito, Yasuhiko ^a   Matsuo, Seiichi ^a   Kobayashi, Takaaki ^b   Maruyama, Shoichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

fat; stem cells; xenoantigen

Indexed keywords

ANTIBODY; FIBROBLAST GROWTH FACTOR 2; HETEROANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; PHYTOHEMAGGLUTININ; SCATTER FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADIPOSE DERIVED STROMAL CELL; ADIPOSE TISSUE CELL; ADULT; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL GROWTH; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOKINE RELEASE; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; RAT; SERUM; SPLEEN CELL; STROMA CELL; SWINE; T LYMPHOCYTE;

ADIPOSE TISSUE; ANIMALS; ANTIBODIES, HETEROPHILE; B-LYMPHOCYTES; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; HUMANS; LEUKOCYTES, MONONUCLEAR; RATS; RATS, INBRED F344; SPLEEN; STROMAL CELLS; SWINE; T-LYMPHOCYTES;

EID: 79959742601     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2011.00640.x     Document Type: Article

References (44)

1. Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G,. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 2007; 56: 1175-1186. (Pubitemid 46608642)
2. Di Nicola M, Carlo-Stella C, Magni M, et al., Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-3843. (Pubitemid 34534559)
3. Aggarwal S, Pittenger MF,. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-1822. (Pubitemid 40223708)
4. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F,. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005; 105: 2821-2827. (Pubitemid 40446275)
5. Augello A, Tasso R, Negrini SM, et al., Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol 2005; 35: 1482-1490. (Pubitemid 40691430)
6. Ge W, Jiang J, Baroja ML, et al., Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am J Transplant 2009; 9: 1760-1772.
7. Bartholomew A, Sturgeon C, Siatskas M, et al., Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42-48. (Pubitemid 34059216)
8. Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE,. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 2006; 108: 2114-2120. (Pubitemid 44395028)
9. Ortiz LA, Dutreil M, Fattman C, et al., Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A 2007; 104: 11002-11007. (Pubitemid 47175216)
10. Gerdoni E, Gallo B, Casazza S, et al., Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 2007; 61: 219-227. (Pubitemid 46557346)
11. Zappia E, Casazza S, Pedemonte E, et al., Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005; 106: 1755-1761. (Pubitemid 41208591)
12. Aksu AE, Horibe E, Sacks J, et al., Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats. Clin Immunol 2008; 127: 348-358.
13. Le Blanc K, Rasmusson I, Sundberg B, et al., Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-1441. (Pubitemid 38586721)
14. Ball LM, Bernardo ME, Roelofs H, et al., Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 2007; 110: 2764-2767. (Pubitemid 47523204)
15. Ankrum J, Karp JM,. Mesenchymal stem cell therapy: two steps forward, one step back. Trends Mol Med 2010; 16: 203-209.
16. Zuk PA, Zhu M, Mizuno H, et al., Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7: 211-228. (Pubitemid 32295155)
17. Puissant B, Barreau C, Bourin P, et al., Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005; 129: 118-129. (Pubitemid 40524060)
18. Yoo KH, Jang IK, Lee MW, et al., Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol 2009; 259: 150-156.
19. Stenderup K, Justesen J, Clausen C, Kassem M,. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003; 33: 919-926. (Pubitemid 37543568)
20. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K,. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006; 24: 1294-1301. (Pubitemid 44464698)
21. Lee RH, Kim B, Choi I, et al., Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004; 14: 311-324. (Pubitemid 39179200)
22. Wagner W, Wein F, Seckinger A, et al., Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 2005; 33: 1402-1416. (Pubitemid 41541969)
23. Chen G, Qian H, Starzl T, et al., Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005; 11: 1295-1298. (Pubitemid 41752909)
24. Miwa Y, Kobayashi T, Nagasaka T, et al., Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation? Xenotransplantation 2004; 11: 247-253. (Pubitemid 38623061)
25. Corcione A, Benvenuto F, Ferretti E, et al., Human mesenchymal stem cells modulate B-cell functions. Blood 2006; 107: 367-372. (Pubitemid 43053565)
26. Comoli P, Ginevri F, Maccario R, et al., Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation. Nephrol Dial Transplant 2008; 23: 1196-1202. (Pubitemid 351767482)
27. Bochev I, Elmadjian G, Kyurkchiev D, et al., Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biol Int 2008; 32: 384-393.
28. Rasmusson I, Le Blanc K, Sundberg B, Ringden O,. Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand J Immunol 2007; 65: 336-343. (Pubitemid 46481102)
29. Traggiai E, Volpi S, Schena F, et al., Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells 2008; 26: 562-569. (Pubitemid 351413617)
30. Iwashima S, Ozaki T, Maruyama S, et al., Novel culture system of mesenchymal stromal cells from human subcutaneous adipose tissue. Stem Cells Dev 2009; 18: 533-543.
31. Okamoto M, Dohi Y, Ohgushi H, et al., Influence of the porosity of hydroxyapatite ceramics on in vitro and in vivo bone formation by cultured rat bone marrow stromal cells. J Mater Sci Mater Med 2006; 17: 327-336.
32. Hara H, Ohdan H, Tashiro H, et al., Differential diagnosis between graft-versus-host disease and hemophagocytic syndrome after living-related liver transplantation by mixed lymphocyte reaction assay. J Invest Surg 2004; 17: 197-202. (Pubitemid 39172990)
33. Parish CR, Glidden MH, Quah BJ, Warren HS,. Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation. Curr Protoc Immunol 2009;Chapter 4:Unit 4.9.
34. Chamberlain G, Fox J, Ashton B, Middleton J,. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007; 25: 2739-2749. (Pubitemid 350127858)
35. Harting M, Jimenez F, Pati S, Baumgartner J, Cox C Jr,. Immunophenotype characterization of rat mesenchymal stromal cells. Cytotherapy 2008; 10: 243-253. (Pubitemid 351566526)
36. Lam TT, Paniagua R, Shivaram G, Schuurman HJ, Borie DC, Morris RE,. Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF-transgenic porcine hearts in cynomolgus monkeys. Xenotransplantation 2004; 11: 531-535. (Pubitemid 39423076)
37. Hering BJ, Wijkstrom M, Graham ML, et al., Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006; 12: 301-303. (Pubitemid 43355076)
38. Gonzalez-Rey E, Gonzalez MA, Varela N, et al., Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis 2009; 69: 241-248.
39. Wolbank S, Peterbauer A, Fahrner M, et al., Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 2007; 13: 1173-1183. (Pubitemid 46986718)
40. Krampera M, Cosmi L, Angeli R, et al., Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006; 24: 386-398. (Pubitemid 44464808)
41. Yanez R, Lamana ML, Garcia-Castro J, Colmenero I, Ramirez M, Bueren JA,. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006; 24: 2582-2591. (Pubitemid 44674320)
42. Jung YD, Nakano K, Liu W, Gallick GE, Ellis LM,. Extracellular signal-regulated kinase activation is required for up-regulation of vascular endothelial growth factor by serum starvation in human colon carcinoma cells. Cancer Res 1999; 59: 4804-4807. (Pubitemid 29472880)
43. Asari S, Itakura S, Ferreri K, et al., Mesenchymal stem cells suppress B-cell terminal differentiation. Exp Hematol 2009; 37: 604-615.
44. Djouad F, Fritz V, Apparailly F, et al., Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 2005; 52: 1595-1603. (Pubitemid 40663952)